Objective Five studies are described to determine whether there is an outermost lining of
surface-active phospholipid (SAPL) adsorbed to the peritoneum and to quantify its ability to …

Objective To investigate whether dialysate concentrations of substances that are locally
produced within the peritoneal cavity can be used to study the effects of inflammation on …

Responding to the rising number of ESRD patients and the increasing importance of dialysis
care and management, Complications of Dialysis provides a comprehensive …

Peritoneal dialysis (PD) is now an established and acceptable mode of treatment for end-
stage renal failure. Whilst in short-term studies PD (3–5 years) has been shown to have a …

Mesothelial cells of uremic nondialyzed patients are normal on light microscopy (3, 5), but
contain cytoplasmatic inclusions in the rough endoplasmatic reticulum on electron …

In this chapter information is given on what can be monitored of the peritoneal membrane.
First the various aspects of mesothelial cell markers are discussed, followed by other …

Peritoneal structural changes are likely to result in functional deterioration of the peritoneal
membrane. For the purpose of early detection of these changes, markers of mesothelial cells …

In 1976, the concept of continuous ambulatory peritoneal dialysis (CAPD) was introduced by
Popovich et al.. It was defined as a novel portable/wearable equilibrium peritoneal dialysis …

BACKGROUND: Postoperative intraperitoneal adhesions are a considerable source of
morbidity. Supplementing compromised endogenous intraperitoneal phospholipids can …

During the past 20 years, our understanding of the process of peritoneal inflammation and
the key role played by mediators (cytokines and prostaglandins) released from both …